Regeneron options active Regeneron September 145 calls are active on total call volume of 1,600 contracts (750 puts). September call option implied volatility is at 31, October is at 34; below its 26-week average of 44 according to Track Data. Active options volume suggests traders are positioning for upside price movement for this frequent takeover name.
News For REGN From The Last 14 Days
Check below for free stories on REGN the last two weeks.
Vertex, Regeneron speculated to be merger targets, TheStreet says Among the predictions for the biotech sector in 2014 made by David Sobek of TheStreet.com was a call for "at least two" mergers between large-cap companies. Sobek predict Sanofi (SNY) will buy Regeneron (REGN) and that Bristol-Myers Squibb (BMY) will acquire Vertex Pharmaceuticals (VRTX). Reference Link